BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy
Clinical trial NCT07597993 · RECRUITING
Trial details
- NCT number
- NCT07597993
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-07-12
- Primary completion
- 2029-03-31
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.